Lycia Therapeutics, Inc. (LYCA)
NASDAQ: LYCA · Real-Time Price · USD
33.07
+1.30 (4.09%)
At close: Nov 20, 2026, 4:00 PM EST
33.30
+0.23 (0.70%)
After-hours: Nov 20, 2026, 7:30 PM EST
Lycia Therapeutics Revenue
Lycia Therapeutics had revenue of $4.44M in the twelve months ending June 30, 2026. In the year 2025, Lycia Therapeutics had annual revenue of $6.74M, down -54.87%. That makes Lycia Therapeutics the 40,413th largest company in the world by revenue and 5,394th in the United States.
Revenue (ttm)
$4.44M
Revenue Growth
-54.87%
P/S Ratio
430.10
Revenue / Employee
$143,065
Employees
31
Market Cap
1.91B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.74M | -8.20M | -54.87% |
| Dec 31, 2024 | 14.94M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
LYCA News
- 3 days ago - Lycia Therapeutics Transcript: Jefferies Global Healthcare Conference - Transcripts
- 5 days ago - Lycia Therapeutics initiated with an Outperform at LifeSci Capital - TheFly
- 5 days ago - Guggenheim starts Lycia Therapeutics with a Buy on food allergy market potential - TheFly
- 5 days ago - Lycia Therapeutics initiated with a Buy at Guggenheim - TheFly
- 5 days ago - Lycia Therapeutics initiated with a Buy at TD Cowen - TheFly
- 5 days ago - Lycia Therapeutics initiated with a Buy at Jefferies - TheFly
- 5 days ago - Lycia Therapeutics initiated with an Outperform at Evercore ISI - TheFly
- 11 days ago - Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire